We expect this quarter to have good uptick for our products: GSK Pharma MD

Q&A with Annaswamy Vaidheesh, MD of GSK Pharmaceuticals India

GlaxoSmithKline (GSK) Pharmaceuticals suffered a 63 per cent decline in net profit in the last quarter as implementation of the goods and services tax (GST) led to de-stocking. Annaswamy Vaidheesh, managing director of the British drug maker’s India unit and vice-president of its operations in South Asia, spoke to Aneesh Phadnis & Abhineet Kumar on the company’s growth strategy in the near future. Edited excerpts:

Is the impact of the GST over now?

We believe we will come out of the de-stocking situation through a re-stocking. This was a big event and expecting normalcy to happen in a couple of months is